Both GIPR and GLP-1R activation lead to an increase in intracellular cAMP levels
[DOI] [PubMed] [Google Scholar] 82.Butiaeva LI, Slutzki T, Swick HE, Bourguignon C, Robins SC, Liu X
The therapeutic benefits including appetite suppression, improved glycaemic control, and any weight loss effects will gradually diminish over the subsequent weeks as drug concentrations decline
doi: 10.1016/j.jpain.2016.11.004 94 Hylands-WhiteNDuarteRVRaphaelJH
Insulin resistance plays an important role in the pathophysiology of comorbid T2DM and depression and can be a trigger for dysregulation of insulin- and GLP-1-mediated signaling (both central and peripheral), neuroendocrine disorders (hypothalamicpituitaryadrenal system dysfunction and monoaminergic neurotransmission disorders), chronic low-intensity inflammation, oxidative stress, and disorders of the microbiota-gut-brain system, reducing the level of neurotrophic factors in the brain and changing synaptic plasticity
PLoS ONE 11 , e0158205 (2016)
